Christophe Jean insider trades
Open-market stock purchases and sales by Christophe Jean, Director at Rhythm Pharmaceuticals, Inc, from SEC Form 4 filings since Jun 6, 2018.
Companies traded
- RYTM Rhythm Pharmaceuticals, Inc: other filings, last Jun 24, 2026